JPRN-UMIN000013694已完成未知
Individualized tacrolimus therapy for ulcerative colitis based on CYP3A5 SNPs - Tacrolimus therapy for ulcerative colitis based on CYP3A5 SNPs
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. women who are pregnant, breastfeeding, or possible to be pregnant 2. individuals who are considered ineligible by the investigator
研究者
相似试验
已完成
不适用
Research on individualisation of tacrolimus regimen based on the CYP3A5, MDR1 and PXR genotypesRenal transplantation/ allograft rejectionInjury, Occupational Diseases, PoisoningFailure and rejection of transplanted organs and tissuesISRCTN24376050Sun Yat-sen University (China)500
进行中（未招募）
1 期
Personalized tacrolimus treatment for pediatric kidney transplant recipients by using a dosing algorithm and a once-daily tacrolimus formulatiopediatric kidney transplant recipientsCTIS2024-511585-36-00Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)28
尚未招募
4 期
Personalized tacrolimus treatment for pediatric kidney transplant recipients by using a dosing algorithm and a once-daily tacrolimus formulation.NL-OMON51392Erasmus MC, Universitair Medisch Centrum Rotterdam28
进行中（未招募）
不适用
Topische Anwendung von Tacrolimus (Protopic) bei verschiedenen Formen des kutanen Lupus erythe-matodes im Rahmen einer klinischen Untersuchung an mehreren nationalen Zentren - entfälltEUCTR2004-005020-41-DEHeinrich Heine Universität Düsseldorf30
招募中
不适用
To study the effect of tacrolimus in patients with lupus nephritisCTRI/2010/091/000264I20